The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a 225,000-square-foot addition to the company’s existing campus off Old Oxford Road.

Merck said that it will be terminating its production of the varicella bulk production drug, used in chickenpox and shingles, at its Durham plant, leading to the loss of 150 full-time Merck ...

Merck has opened a $1 billion, 225,000-square-foot facility at its Durham campus dedicated to vaccine manufacturing, the drug giant announced Tuesday. Merck has opened a $1 billion, 225,000-square ...

Opening highlights effort to expand U.S. manufacturing through a $1 billion investment DURHAM, N.C., March 11, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States ...

At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated to produce bulk substance for its megablockbuster HPV vaccine Gardasil.

The answer has become clearer with news that J&J will use a sprawling Merck & Co. plant in Durham, N.C. to manufacture the bulk drug substance used to make the vaccines, according to the Raleigh ...

Merck is expanding domestic manufacturing with a $895 million investment in its Kansas factory, one of several major projects in the company's strategy to increase U.S. production in the coming years ...

As President Donald Trump hits 100 days in his second term, the administration is touting the billions of investments companies such as Apple and Merck are making in the United States ...